{"id":58952,"date":"2018-08-29T14:48:17","date_gmt":"2018-08-29T18:48:17","guid":{"rendered":"https:\/\/rarediseases.org\/2018-nord-rare-summit-to-feature-distinguished-speakers-discussing-a-new-era-of-patient-focused-innovation\/"},"modified":"2022-12-02T08:11:54","modified_gmt":"2022-12-02T13:11:54","slug":"2018-nord-rare-summit-to-feature-distinguished-speakers-discussing-a-new-era-of-patient-focused-innovation","status":"publish","type":"post","link":"https:\/\/rarediseases.org\/es\/2018-nord-rare-summit-to-feature-distinguished-speakers-discussing-a-new-era-of-patient-focused-innovation\/","title":{"rendered":"2018 NORD Rare Summit to Feature Distinguished Speakers Discussing a New Era of Patient-Focused Innovation"},"content":{"rendered":"

Washington, D.C., August 29, 2018<\/b> – The National Organization for Rare Disorders (NORD), the leading independent nonprofit organization representing the 30 million Americans with rare diseases, has announced some of the speakers confirmed for the <\/span>2018 NORD Rare Diseases & Orphan Products Breakthrough Summit<\/span><\/a>, to be held October 15-16 in Washington, D.C. <\/span><\/p>\n

The NORD Rare Summit, which takes place on an annual basis, is the most innovative multi-stakeholder event of its kind, drawing together more than 700 participants from across the rare disease community to discuss the most current and urgent topics related to rare diseases and orphan products. <\/span><\/p>\n

\u201cA New Era of Patient-Focused Innovation\u201d is the Summit\u2019s 2018 theme, which will be examined from the perspectives of a diverse group of thought leaders. Scott Gottlieb, M.D., Commissioner of the FDA, will provide the Summit\u2019s keynote speech. His will be joined by over 85 voices from the rare disease community, including:<\/span><\/p>\n